• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Waters Corp (WAT)

Common Stock
Sell: $340.00|Buy: $360.27|Change: 0.56 (-0.16%)

Not yet a customer?

Low cost dealing from £1.50

Choose from our range of SIPP, ISA and Dealing accounts

Find out more

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.

Address

34 Maple Street
Milford
MA
USA
01757

Telephone

+1 508 478-2000

Website

https://www.waters.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Waters Corp Second Quarter Earnings Conference Call for 20262026-08-04T08:00:00
Waters Corp Second Quarter Earnings Results for 20262026-08-04T00:00:00
Waters Corp Annual General Meeting for 20262026-05-22T09:00:00
Waters Corp First Quarter Earnings Conference Call for 20262026-05-06T08:00:00
Waters Corp First Quarter Earnings Results for 20262026-05-06T00:00:00
Waters Corp Annual Report for 20252026-02-25T00:00:00
Waters Corp Fourth Quarter Earnings Conference Call for 20252026-02-12T08:00:00
Waters Corp Fourth Quarter Earnings Results for 20252026-02-12T00:00:00
Waters Corp Third Quarter Earnings Conference Call for 20252025-11-04T08:00:00
Waters Corp Third Quarter Earnings Result for 20252025-11-04T00:00:00

Previous key dates

NameKey Date
Waters Corporation to Present at the Wells Fargo Healthcare Conference2025-09-04T09:30:00
Waters Corp Second Quarter Earnings Conference Call for 20252025-08-04T08:00:00
Waters Corp Second Quarter Earnings Result for 20252025-08-04T00:00:00
Waters + BD Biosciences & Diagnostic Solutions Announcement2025-07-14T08:00:00
Jefferies Global Healthcare Conference2025-06-04T08:45:00
Waters Corp Annual General Meeting for 20252025-05-22T09:00:00
Waters Corp First Quarter Earnings Conference Call for 20252025-05-06T08:00:00
Waters Corp First Quarter Earnings Result for 20252025-05-06T00:00:00
Leerink Partners Global Healthcare Conference2025-03-11T10:00:00
Investor Day2025-03-05T08:30:00
Waters Corp Annual Report for 20242025-02-25T00:00:00
Waters Corp Fourth Quarter Earnings Conference Call for 20242025-02-12T08:00:00
Waters Corp Fourth Quarter Earnings Result for 20242025-02-12T00:00:00
43rd Annual J.P. Morgan Healthcare Conference2025-01-13T17:15:00
Waters Corp 7th Annual Evercore HealthCONx Conference 20242024-12-04T10:00:00
Waters Corp Third Quarter Earnings Conference Call for 20242024-11-01T08:00:00
Waters Corp Third Quarter Earnings Result for 20242024-11-01T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.